Emerging
Emerging
Life sciences organizations amid clinical development and raising capital regularly face complex regulatory, risk and financial landscapes. Ensure compliance while improving operational efficiency to reduce costs and enhance productivity, allowing you to focus on innovation. Safeguard your launch and valuation with our robust enterprise risk management (ERM), internal audit and System and Organization Controls (SOCs) services.
- Baker Tilly Advantage for BioTech and MedTech companies
- Assurance
- Cloud-based financial management and accounting: Sage Intacct
- Government and commercial pricing & contracting
- Enterprise risk management
- Specialty tax
Launch
Life sciences companies face new financial and operational challenges as they bring their products to market for the first time. Navigating income taxation and research and development tax credits, is key to maximizing returns, managing risk, and ensuring regulatory compliance, while positioning for long-term growth and profitability.
- Cloud-based financial management and accounting: Sage Intacct
- Enterprise resource planning: IFS
- Life sciences compliance solutions: complianceNOW
- Drug price transparency
- Global spend transparency reporting: transparencyNOW
- Enterprise risk management
- Digital consulting
- Specialty tax
Launch
Scale
scale
Once companies begin generating revenue from their product, companies must scale operations, optimize production processes, and manage supply chain risks, to meet demand sustain growth. Enhancing efficiency, controlling costs and ensuring compliance are essential for success in the competitive market.
- Specialty tax
- Digital consulting
- Scale back-office functions: Oracle Jumpstart
Expansion
As life sciences companies expand through new products, label extensions or enter global markets, they encounter increasingly complex challenges. Engaging with healthcare professionals (HCPs) becomes more intricate, while complying with evolving regulations and transparency obligations becomes more demanding Successfully navigating these complexities is key to driving continued growth and market success.
- Third-party risk management and due diligence
- End-to-end HCP engagement: engagementNOW
- Global spend transparency reporting: transparencyNOW
- Managed care advisory
Expansion
Sustain
As life sciences companies confront patent expirations and increased competition from generics, reinvesting in the business is essential to maintaining market position. Streamlining ethics and compliance programs can improve operational efficiency and ensure regulatory adherence. Additionally, companies may turn to staffing solutions or outsourcing non-core functions to reduce costs and concentrate on strategic initiatives.
- Enterprise risk management
- Compliance and ethics
- AI
- Scale back-office functions: Oracle Jumpstart
Sustain
Prepare for Exit
At any stage, companies may begin evaluating opportunities for an exit, whether through a sale, merger, or licensing agreement. Accurate valuation is critical to securing favorable terms and maximizing returns. Proper preperation including financial assessments, risk management and strategic guidance helps ensure companies are well-positioned to capitalize on these opportunities.
- Valuations
- Enterprise risk management
- Sell side commercial due diligence
Prepare for exit
Exit